Alzheimer’s disease: FDA approves lecanemab amid cost and safety concerns
Elisabeth Mahase
Topics & Concepts
MedicineDiseaseComputer scienceData sciencePathologyCholinesterase and Neurodegenerative DiseasesComputational Drug Discovery MethodsAlzheimer's disease research and treatments